Goldman Sachs Small/Mid Cap Value Class A (GMVAX) Forecast
See the Price Targets and Ratings of:
GMVAX Analyst Rating
Moderate Buy
98ConsensusRatings
88Buy10Hold0Sell
Based on the Wall Street analyst consensus for 98 of GMVAX’s holdings.
GMVAX Analyst Price Target
Average Price Target
$23.55▲(24.72% Upside)
Based on Wall Street analyst 12-month price targets for 98 of Goldman Sachs Small/Mid Cap Value Class A’s holdings in the last 3 months. The average price target is $23.55 with a high forecast of $27.89 and a low forecast of $19.75. The average price target represents a 24.72% change from the last price of $18.88.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$27.89
Average$23.55
Low$19.75
Past 12 Months12 Month Forecast$15$18.25$21.5$24.8$28Feb2026May2026Aug2026Nov2026Nov2027
What is GMVAX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 98 of GMVAX’s holdings, Goldman Sachs Small/Mid Cap Value Class A’s 12-month average price target is $23.55.
What is GMVAX’s upside potential, based on the analysts’ average price target?
GMVAX’s average price target of $23.55 represents a 24.72% upside from its last price of $18.88.
Is GMVAX a Buy, Sell or Hold?
Goldman Sachs Small/Mid Cap Value Class A has a consensus rating of Moderate Buy, based on the analyst consensus for 98 of GMVAX’s holdings: 88 rated Buy, 10 rated Hold and 0 rated Sell.
What is Goldman Sachs Small/Mid Cap Value Class A’s price target?
The average price target for Goldman Sachs Small/Mid Cap Value Class A is $23.55, based on Wall Street analyst 12-month price targets for 98 of GMVAX’s holdings, issued in the past 3 months. The highest price target is $27.89 and the lowest is $19.75. The average price target represents a 24.72% increase from the last price of $18.88.
How can I buy shares of GMVAX?
You can buy shares of GMVAX through a brokerage account. Compare brokers on our Best Online Brokers page.